Mutya Harsch, Chief Legal Officer and GC at VYNE Therapeutics Inc. (VYNE), bought 10,000 shares at $2.50 ($25K) on 2023-03-20, disclosed to the SEC on 2023-03-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |